NEW YORK, July 3 /PRNewswire/ -- Mergent, Inc., administrator for the HealthShares(TM) Indexes, a series of 20 underlying indexes for the HealthShares(TM) Exchange Traded Funds, today announced the following change effective on the opening of trading on Wednesday July 9, 2008: ISTA Pharmaceuticals (Nasdaq: ISTA) will replace Jerini AG (Frankfurt, Germany: JI4) in the HealthShares(TM) Ophthalmology Index. Jerini AG is being acquired by Shire Limited (London Main Market, U.K.: SHP LO).
Companies included in the HealthShares(TM) Ophthalmology Index are engaged in the research, clinical development and/or commercialization of therapeutic agents by means of pharmaceuticals, medical devices or biomaterials for the treatment of various diseases of the eye including, but not limited to, age-related macular degeneration, dry-eye, diabetic macular edema, glaucoma, presbyopia and myopia.
Mergent, Inc., a Xinhua Finance company (TSE Mothers: 9399; OTC ADRs: XHFNY), is the preferred provider of business and financial data on global publicly listed companies. Headquartered in Fort Mill, SC and New York City with sales offices in key North American cities, Mergent also has a strong global presence with offices in London, Shanghai, Tokyo, and Melbourne. Mergent's databases contain detailed financial information on over 35,000 global publicly traded companies from more than 100 countries, 2.2 million U.S. municipal bond issues, 117,000 corporates, and extensive data on dividends, corporate actions and unit investment trusts. Mergent products are unique in the provision of rich textual historical data in financial instruments dating back to the early 1900s.
|SOURCE Mergent, Inc.|
Copyright©2008 PR Newswire.
All rights reserved